What is the recommended treatment for acute idiopathic (viral) pericarditis in an otherwise healthy adult?

Treatment of Acute Idiopathic (Viral) Pericarditis

Treat with combination therapy: high-dose NSAIDs (aspirin 750-1000 mg every 8 hours OR ibuprofen 600 mg every 8 hours) PLUS colchicine (0.5 mg twice daily if ≥70 kg, 0.5 mg once daily if <70 kg) for 3 months, with gastroprotection. 1

First-Line Pharmacotherapy

The 2015 ESC Guidelines provide Class I, Level A recommendations for this dual-therapy approach 1:

NSAIDs/Aspirin:

• Aspirin: 750-1000 mg every 8 hours for 1-2 weeks
• Ibuprofen: 600 mg every 8 hours for 1-2 weeks
• Continue until symptoms resolve AND C-reactive protein (CRP) normalizes
• Taper gradually: decrease aspirin by 250-500 mg every 1-2 weeks; ibuprofen by 200-400 mg every 1-2 weeks
• Always provide gastroprotection (proton pump inhibitor) 1

Colchicine (mandatory adjunct):

• Weight-based dosing: 0.5 mg twice daily (≥70 kg) OR 0.5 mg once daily (<70 kg)
• Duration: 3 months minimum
• Reduces recurrence risk from 37.5% to 16.7% (absolute risk reduction 20.8%) 2
• Tapering not mandatory but can use 0.5 mg every other day in final weeks 1

Critical Treatment Principles

Monitor CRP to guide therapy duration - this is a Class IIa recommendation 1. Treatment duration is symptoms AND CRP-guided, typically 1-2 weeks for uncomplicated cases, but continue full-dose therapy until both resolve.

Common pitfall: Inadequate treatment duration of the first episode is a leading cause of recurrence 1. Don't taper too quickly.

Activity Restriction

• Non-athletes: Restrict physical activity beyond sedentary life until symptoms resolve AND CRP, ECG, and echocardiogram normalize 1
• Athletes: Minimum 3-month restriction from competitive sports after symptom onset, even after normalization of tests 1

Second-Line Therapy (Corticosteroids)

Corticosteroids are NOT recommended as first-line therapy (Class III recommendation) due to risk of chronic evolution and drug dependence 1.

Use low-dose corticosteroids ONLY when:

• Contraindications to NSAIDs/colchicine exist
• Failure of first-line therapy after adequate trial
• Infectious cause has been excluded
• Specific indication exists (e.g., autoimmune disease)

If used: prednisone 0.2-0.5 mg/kg/day (NOT 1.0 mg/kg/day), maintain until symptom resolution and CRP normalization, then taper very slowly 1

Risk Stratification for Outpatient vs. Inpatient Management

Admit to hospital if ANY of these high-risk features present 1:

• Fever >38°C (>100.4°F)
• Subacute course (symptoms over several days without clear acute onset)
• Large pericardial effusion (echo-free space >20 mm)
• Cardiac tamponade
• Failure to respond to NSAIDs within 7 days
• Myopericarditis (elevated troponin)
• Immunosuppression
• Trauma
• Oral anticoagulant therapy

Low-risk patients without these features can be managed as outpatients with close follow-up 1.

Recurrence Management

If recurrence occurs (15-30% risk without colchicine) 1, 2:

• Continue same first-line approach (NSAIDs + colchicine)
• Extend colchicine to at least 6 months 1
• After first recurrence, risk increases to 50% if not optimally treated 1
• For multiple recurrences refractory to standard therapy, consider IL-1 blockers (anakinra) before pericardiectomy 1, 3

What NOT to Do

• Do not use corticosteroids first-line - they increase recurrence rates and promote chronicity 1
• Do not use high-dose corticosteroids (>0.5 mg/kg/day prednisone) 1
• Do not undertaper NSAIDs - this causes recurrence 1
• Do not skip colchicine - it reduces recurrence by approximately 50% 2, 4